—Mkt Cap: —P/E: —
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform in the United States, Germany, and internationally. Its flagship pro…
Industry Peers
Health Care Technologyloading…
Indicators:|
Key Statistics
Company
Market Cap—
Enterprise Value53.35M USD
Revenue (TTM)37.20M USD
Gross Profit26.49M USD
Net Income (TTM)-8.20M USD
Revenue/Share0.5930 USD
Last Price—
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees129
CountryUS
SectorHealth Care
IndustryHealth Care Technology
ISINUS23283X2062
Valuation
P/E (Trailing)—
P/E (Forward)Infinity
PEG—
EV/EBITDA-4.48
EV/Revenue1.43
P/S0.78
P/B13.14
EPS (TTM)-0.19
EPS (Forward)0.00
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin71.48%
Oper. Margin-34.34%
EBITDA Margin-32.04%
Profit Margin-22.12%
ROE-138.88%
ROA-18.56%
Growth
Revenue Growth1.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-12.38M USD
CapEx (TTM)491.00K USD
FCF Margin-12.58%
FCF Yield—
Net Debt24.46M USD
Net Debt/EBITDA-2.05
Balance Sheet
Debt/Equity4.93
Current Ratio1.09
Quick Ratio0.73
Book Value/Sh0.0350 USD
Cash/Share0.0770 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateDec 5, 2014
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)5.250 USD
Target Range0.7500 USD – 10.00 USD
# Analysts3
Ownership
Shares Out.62.79M
Float55.09M
Insiders14.85%
Institutions26.41%
Short Interest
Short Ratio27.8d
Short % Float3.35%
Short % Out.3.25%
Shares Short2.04M
Short (prev mo.)2.02M
Technical
SMA 500.6048 USD
SMA 2000.7492 USD
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)—
Avg Vol (10d)117.51K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—